Endothelin Receptor Antagonists: A New Therapeutic Option for Improving the Outcome after Solid Organ Transplantation?
Journal:
Current Vascular Pharmacology
Volume:
1
Page:
281-299
Author(s):
Uwe Gottmann, Fokko J. van der Woude and Claude Braun
The CNS Melanocortin System: A Biological Weapon Against the Threat of Obesity
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
3
Page:
201-215
Author(s):
M. M. Hagan, P. C. Chandler and P. K. Wauford
VIP and Drug Design
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
483-494
Author(s):
Illana Gozes and Sharon Furman
Normal and Pathological Erectile Function The Potential Clinical Role of Endothelin-1 Antagonists
Journal:
Current Drug Targets
Volume:
1
Page:
247-260
Author(s):
M. A. Khan, R. C. Calvert, M. E. Sullivan, C. S. Thomson, F. H. Mumtaz, R. J. Morgan and D. P. Mikhailidis
Withdrawal Notice: Drug Repurposing for Prospective Anti-Cancer Agents Along with the Clinical Status of the Repurposed Drug
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
20
Page:
1-1
Author(s):
Anjali S. Sabale, Unnati M. Patel, Ankita A. Gorhe, Vinayak R. Bodhankar, Mahesh N. Shinde, Gaurav A. Sonawane, Hitesh S. Raotole, Rohit Y. Pande and Abhijeet D. Kulkarni*